UFLEX Limited has informed the Exchange regarding a press release dated February 12, 2026, titled "Earnings Release for the quarter ended December 31, 2025".
UFLEX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
UFLEX reported Q3 FY26 consolidated revenue of Rs. 36,329 million, down 3.8% YoY and 5.9% QoQ, mainly due to lower packaging film realisations and volumes. Normalized EBITDA stood at Rs. 4,395 million, down 16.1% YoY but up 12.8% QoQ, with margins expanding 200 basis points sequentially to 12.1% as raw material and import pressures eased. Consolidated Q3 PAT fell to Rs. 361 million from Rs. 1,368 million a year ago, hit by higher finance costs, depreciation, and a Rs. 125 million one-time employee benefit provision. On a 9M FY26 basis, revenue was largely flat at Rs. 114,157 million (+0.8% YoY), while the company swung back to a net profit of Rs. 1,211 million versus a Rs. 263 million loss in 9M FY25. The packaging business continued to outperform, with volumes up 7.6% YoY in Q3 and 6.4% YoY in 9M FY26, while aseptic liquid packaging volumes grew 4.4% in 9M FY26. Capex of Rs. 4,342 million in the quarter was directed at aseptic packaging in Egypt, WPP bags in Mexico, and recycling/BOPP capacity in India.
Shareholders see a mixed quarter: a clear sequential recovery in margins and a full 9M swing back to profit, but weak YoY revenue and PAT comparisons, and rising leverage (Net debt/EBITDA at 4.72x versus 3.21x a year ago) keep the stock in a wait-and-watch zone. New capacity commissioning and gradual price recovery in packaging films will be the key triggers for the next few quarters.